Morepen Laboratories Limited (NSE:MOREPENLAB)

Morepen Laboratories Revenue

In the fiscal year ending March 31, 2026, Morepen Laboratories had annual revenue of 18.06B INR, down -0.32%. Morepen Laboratories had revenue of 4.85B in the quarter ending March 31, 2026, with 4.05% growth.

• Revenue: 18.06B
• Revenue Growth: -0.32%
• P/S Ratio: 1.50
• Revenue / Employee: 9.95M
• Employees: 1,814
• Market Cap: 27.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	18.06B	-58.84M	-0.32%
Mar 31, 2025	18.12B	1.21B	7.17%
Mar 31, 2024	16.90B	2.68B	18.88%
Mar 31, 2023	14.22B	-1.34B	-8.60%
Mar 31, 2022	15.56B	3.58B	29.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error